ALPHA IVF GROUP BERHAD
KLSE (MYR): ALPHA (0303)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.315
Today's Change
0.00 (0.00%)
Day's Change
0.315 - 0.32
Trading Volume
1,509,300
Financial
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
Total assets
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current assets
238
1000
110
900
600
Cash & equivalents
238
1000
110
900
600
Short term investments
238
1000
110
900
600
Total receivables, net
238
1000
110
900
600
Accounts receivable - trade, net
238
1000
110
900
600
Other receivables
238
1000
110
900
600
Total inventory
238
1000
110
900
600
Inventories - work in progress
238
1000
110
900
600
Inventories - progress payments & other
238
1000
110
900
600
Inventories - finished goods
238
1000
110
900
600
Inventories - raw materials
238
1000
110
900
600
Total non-current assets
238
1000
110
900
600
Long term investments
238
1000
110
900
600
Note receivable - long term
238
1000
110
900
600
Investments in unconsolidated subsidiaries
238
1000
110
900
600
Other investments
238
1000
110
900
600
Net property/plant/equipment
238
1000
110
900
600
Gross property/plant/equipment
238
1000
110
900
600
Accumulated depreciation, total
238
1000
110
900
600
Deferred tax assets
238
1000
110
900
600
Net intangible assets
238
1000
110
900
600
Other current assets, total
238
1000
110
900
600
Total liabilities
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current liabilities
-238
-1000
-110
-900
-600
Total non-current liabilities
-238
-1000
-110
-900
-600
Long term debt
238
1000
110
900
600
Long term debt excl. lease liabilities
238
1000
110
900
600
Capital and operating lease obligations
238
1000
110
900
600
Provision for risks & charge
-238
-1000
-110
-900
-600
Deferred tax liabilities
-238
-1000
-110
-900
-600
Other liabilities, total
-238
-1000
-110
-900
-600
Total equity
-238
-1.64%
-1000
+11.55%
-110
+81.66%
-900
-13.16%
-600
+235.36%
Total liabilities & shareholders' equities
238B
1000B
110B
900B
600B
Total debt
238
1000
110
900
600
Book value per share
-238
-1000
-110
-900
-600
Discussions
Be the first to like this. Showing 50 of 465 comments
so hard to push up even with those volume, at least alpha is building up the momentum
3 weeks ago
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3514931
I followed Dr. Lee and bought at 33.5 cents
3 weeks ago
only half sen? dream higher la, I wish their business is good so we can get more dividend
2 weeks ago
still havent meet the criteria also, earliest also 2026 only can transfer to main board
2 weeks ago
Dr. Lee bought again. Strong support will be formed at 32 cents
https://klse.i3investor.com/web/insider/detail/D_183655_946568881
1 week ago
Indeed, excellent Q2 performance = good news. Feel free to peruse it 😊
https://klse.i3investor.com/web/blog/detail/NewLifeNewWay/2025-01-22-story-h497934750-Alpha_IVF_Reports_Yet_Another_Record_Q2_FY25_Financial_Results
1 week ago
Alpha IVF Group’s 2QFY5/25 net profit increased 23.6% YoY to RM15.1m thanks to higher sales revenue from foreign patients. Indonesian patients are Alpha IVF’s largest clientele, contributing about 34.9% to its total revenue while patients from China contributed 25.2%. Beyond China, Alpha IVF further expanded in the Southeast Asia region with the establishment of a full-fledged IVF centre in the Philippines and a first satellite clinic in Indonesia, tapping into these rapidly growing markets.
Sadly no dividend announced
1 week ago
Higher sales figures are mostly from foreign patients, good move for Alpha to keep expanding towards China and South East Asia.
1 week ago
Patients dr Indonesia paling byk. Rasa bilangan patient dr Filipina dan Cina juga akan bertmbah scr berdadah pd masa depan
1 week ago
it is undervalued indeed, even analyst forecast that the industry will continue to see decent growth yet the price of the share is not moving at all
1 week ago
The next few quarters should continue to see decent growth, on the back of increased patient volume from China following the launch of the sales representative office
https://www.thestar.com.my/business/business-news/2025/01/23/alpha-ivf-to-see-rising-customer-demand
5 days ago
Alpha said that 2Q25 continued to see a high foreign patient mix, in part due to maiden contribution from the SRO in Shanghai, China. A full quarter’s contribution from the China SRO and the establishment of a satellite clinic in Jakarta, Indonesia should support overall patient volume
5 days ago
even uob still maintaining their buy recommendation, means the current price really below its real value
5 days ago
Short term will get down to 28...it has broken 32 support. No other catalyst until next QR
4 days ago
I dnt think so because there will be another market expansion and it will rebound
1 day ago
Hopefully. Only time will tell. Recent Q earnings did not even move the stock by any means....
1 day ago
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
Dragon Leong blog
2
Stock Market Enthusiast
Feng Shui Market Outlook for FBM KLCI in the Year of the Wood Snake (2025)
3
The Alpha Trader
4
Rakuten Trade Research Reports
5
TA Sector Research
6
Stock Market Enthusiast
3 Resilient Stocks That Defied Malaysia’s Market Slump in January 2025 - #GCB, #ABMB, #CDB
8
MQ Market Updates
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
ryoyagod
The buying volume is strong, and the momentum is positive. Just wait for the imminent surge!
3 weeks ago